In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...

Roy Woodlief, center, poses with Wake County Sheriff Donnie Harrison and Terry Putnam after Woodlief graduated the academy ...

Competing in a marathon could be considered quite the task for some, but not for one Amyotrophic Lateral Sclerosis (ALS) ...

I'm not afraid of dying...I was afraid of living," 83-year-old Barbara Goodfriend said before her death in November ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

Western student applying occupational therapy to her ALS experience to help other families manage their daily lives with physical or cognitive impairment.

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.